The Recall Desk
ModerateFDA (Devices)·Z-2917-2018·Announced 2018-08-29

Elekta Recalls MOSAIQ Oncology Information System Software Due to Status Error

Elekta, Inc. is recalling 185 units of MOSAIQ Oncology Information System software because the order status may incorrectly remain 'Approved' when it should indicate 'Complete'.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, and the source text does not report any hospitalizations, injuries, or deaths, fitting the criteria for a moderate severity software defect.

Plain-English summary

Elekta, Inc. is recalling 185 units of the MOSAIQ Oncology Information System software. The recall involves Software Build(s) 2.64 SP3 and higher. The product was distributed across numerous U.S. states and several international countries, including Australia, Canada, and the United Kingdom.

The recall was initiated because the software exhibits a defect where the order status remains 'Approved' when it should indicate 'Complete'. This error in the oncology information system could potentially impact the tracking of treatment orders.

Healthcare facilities using this software should contact Elekta, Inc. for further instructions on how to address the issue. The recall is classified as Class II by the U.S. Food and Drug Administration.

The recalled product

Product
MOSAIQ Oncology Information System
Manufacturer
Elekta, Inc.
Affected units
185

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • Software Build(s) 2.64 SP3 and higher

Distribution